drugset / Trial / NCT00301080
D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain
RandomizedParallel-groupDouble-blindSupportive care
Summary
D-cycloserine may help lessen pain and other symptoms of peripheral neuropathy caused by chemotherapy. It is not yet known whether D-cycloserine is more effective than a placebo in treating peripheral neuropathy caused by chemotherapy. This randomized, double-blind, placebo-controlled clinical trial was designed to study D-cycloserine at 2 different doses to see how well each works compared to the other and to a placebo in treating cancer patients with peripheral neuropathy caused by chemotherapy.
Timeline
- Start
- 2006-02
- Primary completion
- 2007-02
- Completion
- 2008-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cycloserine | Small molecule | 50 mg | Oral |
| Comparator | Cycloserine | Small molecule | 200 mg | Oral |
| Comparator | Cycloserine | Small molecule | 250 mg | Oral |